Kakoma I, Carson C A, Ristic M, Stephenson E M, Hildebrandt P K, Huxsoll D L
Infect Immun. 1978 Apr;20(1):242-7. doi: 10.1128/iai.20.1.242-247.1978.
A platelet migration inhibition test was devised to determine the presence of antiplatelet activity in serum collected from experimentally produced and natural cases of canine ehrlichiosis. The maximum platelet migration inhibition effect was observed during the acute phase of the disease and before the appearance of specific humoral antibody, measured by the indirect fluorescent-antibody test. Platelet migration inhibition may be one of the earliest events leading to pancytopenia. In most cases, sera positive for humoral antibodies also were positive for platelet migration inhibition, although no direct correlation was evident between the serological titer and the degree of platelet migration inhibition. Inoculation of dogs with uninfected canine blood did not induce the production of inhibition factor or antibody activity, which precluded a histocompatibility response to the cellular elements in the inoculum. Scanning electron microscopy indicated that the platelet inhibition factor interfered with platelet migration by inhibiting pseudopod formation. Affected platelets became rounded and showed evidence of clumping and leakage.
设计了一项血小板迁移抑制试验,以确定从实验性诱导和自然感染的犬埃立克体病病例采集的血清中是否存在抗血小板活性。在疾病急性期以及通过间接荧光抗体试验测定的特异性体液抗体出现之前,观察到最大的血小板迁移抑制效果。血小板迁移抑制可能是导致全血细胞减少的最早事件之一。在大多数情况下,体液抗体阳性的血清血小板迁移抑制也呈阳性,尽管血清学滴度与血小板迁移抑制程度之间没有明显的直接相关性。用未感染的犬血接种犬不会诱导抑制因子或抗体活性的产生,这排除了对接种物中细胞成分的组织相容性反应。扫描电子显微镜显示,血小板抑制因子通过抑制伪足形成来干扰血小板迁移。受影响的血小板变得圆钝,并出现聚集和渗漏迹象。